Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Karessa Pharma AB
AB
Dissolved
Org 5569667420
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2014 · 12 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Karessa Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
PG
Per Gustaf Hammar
Chief Auditor
Chief Auditor
2026
EN
Eric Niklas Nordström
Chief Auditor
Chief Auditor
2020
Former (2)
JP
Jesper Paul Fredrik Wiklund
Chief Executive Officer
Chief Executive Officer
2022 – 2023
MA
Mats Anders Nilsson
Chief Executive Officer
Chief Executive Officer
2020 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
CF
Claes Fredrik Hübinette
Board of Directors
Board of Directors
2020
CS
Charles Scott Boyer
Deputy Board Member
Deputy Board Member
2023
Former (2)
JP
Jesper Paul Fredrik Wiklund
Deputy Board Member
Deputy Board Member
2022 – 2023
MA
Mats Anders Nilsson
Deputy Board Member
Deputy Board Member
2020 – 2022
Shareholders
As of last annual report
Klaria Pharma Holding AB (publ) — 100%
100%
Shareholder
Type
Ownership
Votes
Since
Klaria Pharma Holding AB (publ)
Company
100%
100%
0001
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Karessa Pharma AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
